Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is Fourth Sail Capital LP’s 6th Largest Position

Fourth Sail Capital LP increased its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report) by 20.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,961,825 shares of the company’s stock after purchasing an additional 334,195 shares during the quarter. Bioceres Crop Solutions accounts for approximately 5.0% of Fourth Sail Capital LP’s investment portfolio, making the stock its 6th largest holding. Fourth Sail Capital LP owned 3.12% of Bioceres Crop Solutions worth $21,992,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of BIOX. Cape Investment Advisory Inc. purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter valued at about $33,000. Oppenheimer & Co. Inc. acquired a new position in Bioceres Crop Solutions in the first quarter valued at approximately $139,000. Lazard Asset Management LLC purchased a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $212,000. Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $448,000. Finally, Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Bioceres Crop Solutions during the 2nd quarter valued at approximately $472,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Analysts Set New Price Targets

BIOX has been the topic of several analyst reports. Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Lake Street Capital reduced their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Oppenheimer dropped their price objective on Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating on the stock in a report on Wednesday, September 11th. Finally, Roth Capital raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $13.63.

Get Our Latest Stock Analysis on BIOX

Bioceres Crop Solutions Stock Up 0.5 %

BIOX opened at $8.60 on Tuesday. The company has a market cap of $540.05 million, a PE ratio of 860.00 and a beta of 0.49. Bioceres Crop Solutions Corp. has a twelve month low of $8.16 and a twelve month high of $14.05. The company has a 50-day moving average price of $10.39 and a 200 day moving average price of $11.37. The company has a quick ratio of 0.83, a current ratio of 1.28 and a debt-to-equity ratio of 0.35.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last released its earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. The firm had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter last year, the business earned ($0.06) EPS. Sell-side analysts expect that Bioceres Crop Solutions Corp. will post 0.81 earnings per share for the current fiscal year.

About Bioceres Crop Solutions

(Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Read More

Institutional Ownership by Quarter for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.